P38 inhibitors were used to reduce dux4 performance.

摘要

T. P current invention; oacute; n refers to compounds and M amp; eacute; all in order to inhibit cnasa p38 to reduce expression and the genes and genes of amp; oacute; n de prote amp; Iacute; dux4 and the subsequent dux4 gene. Present inventionP. Oacute; n refers to ADEM amp; Aacute; s a M amp; eacute; all patients with diseases and diseases due to increased expression and amp; oacute; n de dux4 or La premi amp; oacute; n refers to amp; oacute; n refers to amp; oacute; Mala de dux4Such as facial muscle atrophy (FSHD) P